Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New molecular pathways in angiogenesis.

D C Sullivan1, R Bicknell

  • 1Molecular Angiogenesis Laboratory, Cancer Research UK, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DS, UK.

British Journal of Cancer
|July 17, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of respiratory gating on improving volume measurement of murine lung tumors in micro-CT imaging.

PloS one·2020
Same author

Multimerin-2 is a ligand for group 14 family C-type lectins CLEC14A, CD93 and CD248 spanning the endothelial pericyte interface.

Oncogene·2017
Same author

Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth.

Oncogenesis·2017
Same author

Blocking CLEC14A-MMRN2 binding inhibits sprouting angiogenesis and tumour growth.

Oncogene·2015
Same author

Identification of novel vascular targets in lung cancer.

British journal of cancer·2014
Same author

The effects of CCR5 inhibition on regulatory T-cell recruitment to colorectal cancer.

British journal of cancer·2014
Same journal

Efficacy and safety of a novel oral anti-vasculogenic mimicry agent, CVM-1118, in advanced well-differentiated neuroendocrine tumors: a Phase IIa trial.

British journal of cancer·2026
Same journal

Altretamine induces ferroptosis in small cell lung cancer by promoting epigenetic silencing and lysosomal degradation of GPX4.

British journal of cancer·2026
Same journal

Revisiting retinoic acid in AML therapy: mechanisms of action and rational combination strategies.

British journal of cancer·2026
Same journal

De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.

British journal of cancer·2026
Same journal

Planetary Health Diet Index and breast cancer risk.

British journal of cancer·2026
Same journal

Can national lung cancer screening programs be implemented without exacerbating social disparities?

British journal of cancer·2026
See all related articles

New signalling pathways are key to understanding tumor angiogenesis. Molecules like ephrin/Eph receptors and Notch/delta offer promising anti-cancer therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Angiogenesis, the formation of new blood vessels, is crucial for tumor growth and metastasis.
  • Dysregulated angiogenesis is a hallmark of cancer, making it a significant area of research.
  • Recent discoveries have identified novel signaling pathways involved in both normal and pathological angiogenesis.

Purpose of the Study:

  • To review recent developments in the study of angiogenesis.
  • To highlight newly identified signaling pathways implicated in tumor angiogenesis.
  • To identify potential anti-cancer therapeutic targets within these pathways.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of signaling pathways involved in angiogenesis.

Related Experiment Videos

  • Identification of key molecular players and their therapeutic potential.

    • Main Results:

    • Several novel signaling pathways, including ephrin/Eph receptor, Notch/delta, sprouty, hedgehog, and roundabout/slit families, play roles in angiogenesis.
    • Molecules within these pathways are potential targets for novel anti-cancer therapies.
    • Understanding these pathways is critical for developing new anti-cancer strategies.

    Conclusions:

    • Targeting specific molecular pathways involved in angiogenesis holds promise for cancer treatment.
    • Further research into ephrin/Eph, Notch/delta, sprouty, hedgehog, and roundabout/slit families could lead to effective anti-cancer drugs.
    • The identified signaling molecules represent a new frontier in the development of targeted cancer therapies.